German Life Sciences Property Market Enters a More Selective Phase

The German life sciences property market is entering a more selective phase, as reported by a study from Colliers and ESPG. The demand for modern laboratory space remains strong, highlighting the sector's need for standardised processes and reliable regulatory frameworks. Despite technological advances like artificial intelligence, physical labs remain essential. The market is influenced by changing capital conditions, with high-quality core properties gaining focus.

In 2026, €112 million in transactions were noted, indicating recovery from pandemic-induced downturns. Investors concentrate on quality properties in Munich, Berlin, and other clusters, given the market's stable cash flows and low vacancy rates. The segment offers opportunities for investors familiar with its nuances, despite its complexity.